Gong Hongjia
Angel Investor · at Jiadao Capital
Gong Hongjia is a angel investor at Jiadao Capital focused on Biotechnology and Medical. Gong Hongjia is the the founder of Jiadao Capital.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 64%
Last updated:
For AI agents: llms.txt
Industries Gong Hongjia invests in
Stages Gong Hongjia invests in
Countries Gong Hongjia invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Angel
- $1.4M–$14M
Investment Focus
Industry
- Biotechnology 4 (36%)
- Medical 3 (27%)
- Life Science 2 (18%)
- Pharmaceutical 2 (18%)
- Audio 1 (9%)
Stage
- Angel 4 (36%)
- Seed 2 (18%)
- Series B 1 (9%)
- Series C 1 (9%)
- Corporate Round 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Snow Origin is a Beijing deep-tech company specializing in neural interfaces and surface EMG (sEMG) interaction. They build BCI peripheral hardware to deliver natural, stable human-computer interaction for next-generation AR/VR headsets and smart devices. | Angel / Jun 23, 2026 | ||
Jiansheng Medicine
|
Jianersheng Pharmaceutical is a manufacturer of heavy metal detoxification drugs. It company is primarily involved in the research, development, and sale of special heavy metal detoxification drugs, such as special heavy metal detoxifiers and heavy metal diagnostic rapid detection kits. | $14M / Series B / Nov 03, 2025 | |
| Meyer FSMP Hong Kong leads the research and development and practical exploration of the oncology special medical food industry.With the support of Hong Kong Meiya Pharmaceutical Factory with nearly 50 years of pharmaceutical history, and with the cooperation of the Chinese mainland oncology product promotion team with 30 years of successfulexperience, Meyer FSMP has entered the special medical food industry across the board, leading the development of domestic nutrition therapy, and is committed to becoming a practitioner of the first-line treatment of tumor nutrition. | Corporate Round / Oct 24, 2025 | ||
| Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. | Seed / May 22, 2025 | ||
| Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. | $13.9M / Angel / May 22, 2025 | ||
|
Rongxiu Shengsheng
|
Rongxiu Shengsheng specializes in industrial transformation and development of herbal plant essential oils for medicinal and cosmetic use. | $1.4M / Angel / Apr 11, 2025 | |
CapitalBio Pharma
|
CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation. | $5.6M / Angel / Jan 04, 2024 | |
| POROSVOC is an audio processing technology company that offers chip-level core services for intelligent voice enhancement and intelligent voice interaction solutions for financial equipment, communication equipment, robots, smart home products, small household appliances, and other industries. | Angel / Aug 02, 2023 | ||
| KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine. | Seed / Nov 08, 2022 | ||
| Dao Biolink is an information system integration and Internet of Things technology service provider. | $14.9M / Series A / May 25, 2022 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Gong Hongjia invest in?
Gong Hongjia invests primarily in Biotechnology, Medical and Life Science startups, most often at Angel and Seed stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Gong Hongjia's check size?
Gong Hongjia typically joins rounds of $1.4M–$14M at Angel. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gong Hongjia participates in.
How do I contact Gong Hongjia?
Public channels for Gong Hongjia include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gong Hongjia last invest?
The most recent investment recorded for Gong Hongjia closed in Jun 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
